Skip to content

In the BioHarmony Drug Report Database

Thioguanine

Thioguanine (thioguanine) is a small molecule pharmaceutical. Thioguanine was first approved as Thioguanine on 1982-01-01. It is used to treat basophilic leukemia acute, bcr-abl positive chronic myelogenous leukemia, eosinophilic leukemia acute, neutrophilic leukemia chronic, and psoriasis in the USA. The pharmaceutical is active against inosine-5'-monophosphate dehydrogenase 2 and inosine-5'-monophosphate dehydrogenase 1. In addition, it is known to target 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine diphosphokinase.
Trade Name Thioguanine
Common Name Thioguanine
Indication basophilic leukemia acute, bcr-abl positive chronic myelogenous leukemia, eosinophilic leukemia acute, neutrophilic leukemia chronic, psoriasis
Drug Class
Thioguanine
Get full access now